These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23977314)

  • 1. Association between 1p11-rs11249433 polymorphism and breast cancer susceptibility: evidence from 15 case-control studies.
    Wu S; Cai J; Wang H; Zhang H; Yang W
    PLoS One; 2013; 8(8):e72526. PubMed ID: 23977314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing interactions between the association of common genetic variant at 1p11 (rs11249433) and hormone receptor status with breast cancer risk.
    Chen Q; Shi R; Liu W; Jiang D
    PLoS One; 2013; 8(8):e72487. PubMed ID: 23977306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.
    Figueroa JD; Garcia-Closas M; Humphreys M; Platte R; Hopper JL; Southey MC; Apicella C; Hammet F; Schmidt MK; Broeks A; Tollenaar RA; Van't Veer LJ; Fasching PA; Beckmann MW; Ekici AB; Strick R; Peto J; dos Santos Silva I; Fletcher O; Johnson N; Sawyer E; Tomlinson I; Kerin M; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Bojesen S; Flyger H; Nordestgaard BG; Benítez J; Milne RL; Ignacio Arias J; Zamora MP; Brenner H; Müller H; Arndt V; Rahman N; Turnbull C; Seal S; Renwick A; Brauch H; Justenhoven C; Brüning T; ; Chang-Claude J; Hein R; Wang-Gohrke S; Dörk T; Schürmann P; Bremer M; Hillemanns P; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Bogdanova N; Antonenkova N; Rogov YI; Karstens JH; Bermisheva M; Prokofieva D; Gantcev SH; Khusnutdinova E; Lindblom A; Margolin S; Chenevix-Trench G; Beesley J; Chen X; ; Mannermaa A; Kosma VM; Soini Y; Kataja V; Lambrechts D; Yesilyurt BT; Chrisiaens MR; Peeters S; Radice P; Peterlongo P; Manoukian S; Barile M; Couch F; Lee AM; Diasio R; Wang X; Giles GG; Severi G; Baglietto L; Maclean C; Offit K; Robson M; Joseph V; Gaudet M; John EM; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis I; Knight JA; Mulligan AM; O'Malley FP; Brinton LA; Sherman ME; Lissowska J; Chanock SJ; Hooning M; Martens JW; van den Ouweland AM; Collée JM; Hall P; Czene K; Cox A; Brock IW; Reed MW; Cross SS; Pharoah P; Dunning AM; Kang D; Yoo KY; Noh DY; Ahn SH; Jakubowska A; Lubinski J; Jaworska K; Durda K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Shen CY; Ding SL; Hsu HM; Yu JC; Anton-Culver H; Ziogas A; Ashworth A; Swerdlow A; Jones M; Orr N; Trentham-Dietz A; Egan K; Newcomb P; Titus-Ernstoff L; Easton D; Spurdle AB
    Hum Mol Genet; 2011 Dec; 20(23):4693-706. PubMed ID: 21852249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.
    Horne HN; Chung CC; Zhang H; Yu K; Prokunina-Olsson L; Michailidou K; Bolla MK; Wang Q; Dennis J; Hopper JL; Southey MC; Schmidt MK; Broeks A; Muir K; Lophatananon A; Fasching PA; Beckmann MW; Fletcher O; Johnson N; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Flyger H; Benitez J; González-Neira A; Anton-Culver H; Neuhausen SL; Brenner H; Arndt V; Meindl A; Schmutzler RK; Brauch H; Hamann U; Nevanlinna H; Khan S; Matsuo K; Iwata H; Dörk T; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kosma VM; Chenevix-Trench G; ; Wu AH; Ven den Berg D; Smeets A; Zhao H; Chang-Claude J; Rudolph A; Radice P; Barile M; Couch FJ; Vachon C; Giles GG; Milne RL; Haiman CA; Marchand LL; Goldberg MS; Teo SH; Taib NA; Kristensen V; Borresen-Dale AL; Zheng W; Shrubsole M; Winqvist R; Jukkola-Vuorinen A; Andrulis IL; Knight JA; Devilee P; Seynaeve C; García-Closas M; Czene K; Darabi H; Hollestelle A; Martens JW; Li J; Lu W; Shu XO; Cox A; Cross SS; Blot W; Cai Q; Shah M; Luccarini C; Baynes C; Harrington P; Kang D; Choi JY; Hartman M; Chia KS; Kabisch M; Torres D; Jakubowska A; Lubinski J; Sangrajrang S; Brennan P; Slager S; Yannoukakos D; Shen CY; Hou MF; Swerdlow A; Orr N; Simard J; Hall P; Pharoah PD; Easton DF; Chanock SJ; Dunning AM; Figueroa JD
    PLoS One; 2016; 11(8):e0160316. PubMed ID: 27556229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations.
    Fu YP; Edvardsen H; Kaushiva A; Arhancet JP; Howe TM; Kohaar I; Porter-Gill P; Shah A; Landmark-Høyvik H; Fosså SD; Ambs S; Naume B; Børresen-Dale AL; Kristensen VN; Prokunina-Olsson L
    Mol Cancer; 2010 May; 9():113. PubMed ID: 20482849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing interactions between common genetic variant on 2q35 and hormone receptor status with breast cancer risk: evidence based on 26 studies.
    Huang T; Hong J; Lin W; Yang Q; Ni K; Wu Q; Sun J
    PLoS One; 2013; 8(8):e69056. PubMed ID: 23976942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants at 1p11.2 and breast cancer risk: a two-stage study in Chinese women.
    Jiang Y; Shen H; Liu X; Dai J; Jin G; Qin Z; Chen J; Wang S; Wang X; Hu Z; Shen H
    PLoS One; 2011; 6(6):e21563. PubMed ID: 21738711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between 5p12 genomic markers and breast cancer susceptibility: evidence from 19 case-control studies.
    Wang X; Zhang L; Chen Z; Ma Y; Zhao Y; Rewuti A; Zhang F; Fu D; Han Y
    PLoS One; 2013; 8(9):e73611. PubMed ID: 24039999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression.
    Horne HN; Sherman ME; Garcia-Closas M; Pharoah PD; Blows FM; Yang XR; Hewitt SM; Conway CM; Lissowska J; Brinton LA; Prokunina-Olsson L; Dawson SJ; Caldas C; Easton DF; Chanock SJ; Figueroa JD
    Breast Cancer Res Treat; 2014 Jan; 143(1):181-7. PubMed ID: 24292867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of the association between rs2046210 at 6q25.1 and breast cancer risk.
    Wu X; Xu QQ; Guo L; Yu CT; Xiong YY; Wei ZY; Huo R; Li ST; Shen L; Niu JM; Liu L; Lin Y; He L; Qin SY
    PLoS One; 2013; 8(6):e65206. PubMed ID: 23785413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC).
    Hein R; Maranian M; Hopper JL; Kapuscinski MK; Southey MC; Park DJ; Schmidt MK; Broeks A; Hogervorst FB; Bueno-de-Mesquita HB; Muir KR; Lophatananon A; Rattanamongkongul S; Puttawibul P; Fasching PA; Hein A; Ekici AB; Beckmann MW; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Sawyer E; Tomlinson I; Kerin M; Miller N; Marmee F; Schneeweiss A; Sohn C; Burwinkel B; Guénel P; Cordina-Duverger E; Menegaux F; Truong T; Bojesen SE; Nordestgaard BG; Flyger H; Milne RL; Perez JI; Zamora MP; Benítez J; Anton-Culver H; Ziogas A; Bernstein L; Clarke CA; Brenner H; Müller H; Arndt V; Stegmaier C; Rahman N; Seal S; Turnbull C; Renwick A; Meindl A; Schott S; Bartram CR; Schmutzler RK; Brauch H; Hamann U; Ko YD; ; Wang-Gohrke S; Dörk T; Schürmann P; Karstens JH; Hillemanns P; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Bogdanova NV; Zalutsky IV; Antonenkova NN; Bermisheva M; Prokovieva D; Farahtdinova A; Khusnutdinova E; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen J; Chen X; Beesley J; ; ; Lambrechts D; Zhao H; Neven P; Wildiers H; Nickels S; Flesch-Janys D; Radice P; Peterlongo P; Manoukian S; Barile M; Couch FJ; Olson JE; Wang X; Fredericksen Z; Giles GG; Baglietto L; McLean CA; Severi G; Offit K; Robson M; Gaudet MM; Vijai J; Alnæs GG; Kristensen V; Børresen-Dale AL; John EM; Miron A; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Figueroa JD; García-Closas M; Lissowska J; Sherman ME; Hooning M; Martens JW; Seynaeve C; Collée M; Hall P; Humpreys K; Czene K; Liu J; Cox A; Brock IW; Cross SS; Reed MW; Ahmed S; Ghoussaini M; Pharoah PD; Kang D; Yoo KY; Noh DY; Jakubowska A; Jaworska K; Durda K; Złowocka E; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Shen CY; Yu JC; Hsu HM; Hou MF; Orr N; Schoemaker M; Ashworth A; Swerdlow A; Trentham-Dietz A; Newcomb PA; Titus L; Egan KM; Chenevix-Trench G; Antoniou AC; Humphreys MK; Morrison J; Chang-Claude J; Easton DF; Dunning AM
    PLoS One; 2012; 7(8):e42380. PubMed ID: 22879957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk.
    Wang H; Yang Z; Zhang H
    Breast Cancer Res Treat; 2013 Jan; 137(2):511-22. PubMed ID: 23184080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of common genetic variants on chromosome 5p12 and hormone receptor status with breast cancer risk.
    Yu Y; Chen Z; Wang H; Zhang Y
    PLoS One; 2013; 8(8):e72154. PubMed ID: 23977236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).
    Thomas G; Jacobs KB; Kraft P; Yeager M; Wacholder S; Cox DG; Hankinson SE; Hutchinson A; Wang Z; Yu K; Chatterjee N; Garcia-Closas M; Gonzalez-Bosquet J; Prokunina-Olsson L; Orr N; Willett WC; Colditz GA; Ziegler RG; Berg CD; Buys SS; McCarty CA; Feigelson HS; Calle EE; Thun MJ; Diver R; Prentice R; Jackson R; Kooperberg C; Chlebowski R; Lissowska J; Peplonska B; Brinton LA; Sigurdson A; Doody M; Bhatti P; Alexander BH; Buring J; Lee IM; Vatten LJ; Hveem K; Kumle M; Hayes RB; Tucker M; Gerhard DS; Fraumeni JF; Hoover RN; Chanock SJ; Hunter DJ
    Nat Genet; 2009 May; 41(5):579-84. PubMed ID: 19330030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between a novel polymorphism (rs2046210) of the 6q25.1 locus and breast cancer risk.
    Yang Z; Shen J; Cao Z; Wang B
    Breast Cancer Res Treat; 2013 May; 139(1):267-75. PubMed ID: 23609471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer.
    Huo D; Feng Y; Haddad S; Zheng Y; Yao S; Han YJ; Ogundiran TO; Adebamowo C; Ojengbede O; Falusi AG; Zheng W; Blot W; Cai Q; Signorello L; John EM; Bernstein L; Hu JJ; Ziegler RG; Nyante S; Bandera EV; Ingles SA; Press MF; Deming SL; Rodriguez-Gil JL; Nathanson KL; Domchek SM; Rebbeck TR; Ruiz-Narváez EA; Sucheston-Campbell LE; Bensen JT; Simon MS; Hennis A; Nemesure B; Leske MC; Ambs S; Chen LS; Qian F; Gamazon ER; Lunetta KL; Cox NJ; Chanock SJ; Kolonel LN; Olshan AF; Ambrosone CB; Olopade OI; Palmer JR; Haiman CA
    Hum Mol Genet; 2016 Nov; 25(21):4835-4846. PubMed ID: 28171663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium.
    Warren H; Dudbridge F; Fletcher O; Orr N; Johnson N; Hopper JL; Apicella C; Southey MC; Mahmoodi M; Schmidt MK; Broeks A; Cornelissen S; Braaf LM; Muir KR; Lophatananon A; Chaiwerawattana A; Wiangnon S; Fasching PA; Beckmann MW; Ekici AB; Schulz-Wendtland R; Sawyer EJ; Tomlinson I; Kerin M; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Guénel P; Truong T; Laurent-Puig P; Mulot C; Bojesen SE; Nielsen SF; Flyger H; Nordestgaard BG; Milne RL; Benítez J; Arias-Pérez JI; Zamora MP; Anton-Culver H; Ziogas A; Bernstein L; Dur CC; Brenner H; Müller H; Arndt V; Langheinz A; Meindl A; Golatta M; Bartram CR; Schmutzler RK; Brauch H; Justenhoven C; Brüning T; ; Chang-Claude J; Wang-Gohrke S; Eilber U; Dörk T; Schürmann P; Bremer M; Hillemanns P; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Bogdanova N; Antonenkova N; Rogov Y; Bermisheva M; Prokofyeva D; Zinnatullina G; Khusnutdinova E; Lindblom A; Margolin S; Mannermaa A; Kosma VM; Hartikainen JM; Kataja V; Chenevix-Trench G; Beesley J; Chen X; ; ; Lambrechts D; Smeets A; Paridaens R; Weltens C; Flesch-Janys D; Buck K; Behrens S; Peterlongo P; Bernard L; Manoukian S; Radice P; Couch FJ; Vachon C; Wang X; Olson J; Giles G; Baglietto L; McLean CA; Severi G; John EM; Miron A; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis IL; Knight JA; Mulligan AM; Weerasooriya N; Devilee P; Tollenaar RA; Martens JW; Seynaeve CM; Hooning MJ; Hollestelle A; Jager A; Tilanus-Linthorst MM; Hall P; Czene K; Liu J; Li J; Cox A; Cross SS; Brock IW; Reed MW; Pharoah P; Blows FM; Dunning AM; Ghoussaini M; Ashworth A; Swerdlow A; Jones M; Schoemaker M; Easton DF; Humphreys M; Wang Q; Peto J; dos-Santos-Silva I
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1783-91. PubMed ID: 22859399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common genetic variants (rs4779584 and rs10318) at 15q13.3 contributes to colorectal adenoma and colorectal cancer susceptibility: evidence based on 22 studies.
    Tu L; Yan B; Peng Z
    Mol Genet Genomics; 2015 Jun; 290(3):901-12. PubMed ID: 25475391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of 2q35-rs13387042 polymorphism and hormone receptor status with breast cancer risk.
    Gu C; Zhou L; Yu J
    PLoS One; 2013; 8(7):e66979. PubMed ID: 23894282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of the influence of common variations on 6p21 and lung cancer risk.
    TanTai J; Shen Y; Zhao H
    Tumour Biol; 2014 Jan; 35(1):689-94. PubMed ID: 23959479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.